THE EFFECT OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-DELTA AGONIST ON ACTIVATED INFLAMMASOME IN MODELS OF NONALCOHOLIC FATTY LIVER DISEASE

被引：0

作者：

Lee, H. J. ^{[1
]}

Yeon, J. E. ^{[1
]}

Ko, E. J. ^{[1
]}

Yoon, E. L. ^{[1
]}

Suh, S. J. ^{[1
]}

Kang, K. ^{[1
]}

Kim, H. R. ^{[1
]}

Kang, S. H. ^{[1
]}

Yoo, Y. J. ^{[1
]}

Je, J. ^{[1
]}

Kim, J. H. ^{[1
]}

Seo, Y. S. ^{[1
]}

Yim, H. J. ^{[1
]}

Um, S. H. ^{[1
]}

Byun, K. S. ^{[1
]}

机构：

[1] Korea Univ, Coll Med, Dept Internal Med, Seoul 136705, South Korea

来源：

JOURNAL OF HEPATOLOGY | 2014年 / 60卷 / 01期

关键词：

D O I：

10.1016/S0168-8278(14)60418-9

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

P256

引用

页码：S150 / S150

页数：1

共 50 条

[31] Effects of peroxisome proliferator-activated receptor agonists on murine nonalcoholic liver injury.
Fujii, K
Nishitani, Y
Matsumoto, H
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2004, 28 (08) : 10A - 10A
[32] Peroxisome Proliferator-Activated Receptor-δ as Emerging Target in Liver Disease
Schnabl, Bernd
DRUG DEVELOPMENT RESEARCH, 2010, 71 (02) : 106 - 111
[33] Role of hepatic peroxisome proliferator-activated receptor γ in non-alcoholic fatty liver disease
Lee, Samuel M.
Muratalla, Jose
Sierra-Cruz, Marta
Cordoba-Chacon, Jose
JOURNAL OF ENDOCRINOLOGY, 2023, 257 (01)
[34] Peroxisome proliferator-activated receptor in liver diseases.
赵彩彦
姜玲玲
中华肝脏病杂志, 2003, (06) : 63 - 65
[35] The role of peroxisome proliferator-activated receptor in the treatment of non-alcoholic fatty liver disease
Sun, Xin
Zhang, Yan
Xie, Meilin
ACTA PHARMACEUTICA, 2017, 67 (01) : 1 - 13
[36] Lichen Planopilaris Treated With a Peroxisome Proliferator-Activated Receptor γ Agonist
Mirmirani, Paradi
Karnik, Pratima
ARCHIVES OF DERMATOLOGY, 2009, 145 (12) : 1363 - 1366
[37] Peroxisome Proliferator-Activated Receptor and Retinoic X Receptor in Alcoholic Liver Disease
Mello, Tommaso
Polvani, Simone
Galli, Andrea
PPAR RESEARCH, 2009, 2009
[38] Partial peroxisome proliferator-activated receptor agonist angiotensin receptor blockers
Towfighi, Amytis
Ovbiagele, Bruce
CEREBROVASCULAR DISEASES, 2008, 26 (02) : 106 - 112
[39] Effect of peroxisome proliferator-activated receptor γ agonist, rosiglitazone, on dedifferentiated thyroid cancers
Philips, JC
Petite, C
Willi, JP
Buchegger, F
Meier, CA
NUCLEAR MEDICINE COMMUNICATIONS, 2004, 25 (12) : 1183 - 1186
[40] Expression profiling of Peroxisome proliferator-activated receptor-delta (PPAR-delta) in mouse tissues using tissue microarray
Higashiyama, Hiroyuki
Billin, Andrew N.
Okamoto, Yuji
Kinoshita, Mine
Asano, Satoshi
HISTOCHEMISTRY AND CELL BIOLOGY, 2007, 127 (05) : 485 - 494

← 1 2 3 4 5 →